Uniphar (UPR) Competitors GBX 174 +6.00 (+3.57%) (As of 11/21/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividend UPR vs. UDG, CLIN, EMIS, ONT, GNS, INDV, VEC, SPI, CTH, and CRWShould you be buying Uniphar stock or one of its competitors? The main competitors of Uniphar include UDG Healthcare (UDG), Clinigen Group (CLIN), EMIS Group (EMIS), Oxford Nanopore Technologies (ONT), Genus (GNS), Indivior (INDV), Vectura Group (VEC), Spire Healthcare Group (SPI), CareTech (CTH), and Craneware (CRW). These companies are all part of the "medical" sector. Uniphar vs. UDG Healthcare Clinigen Group EMIS Group Oxford Nanopore Technologies Genus Indivior Vectura Group Spire Healthcare Group CareTech Craneware Uniphar (LON:UPR) and UDG Healthcare (LON:UDG) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, community ranking, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations. Does the media favor UPR or UDG? In the previous week, Uniphar's average media sentiment score of 0.00 equaled UDG Healthcare'saverage media sentiment score. Company Overall Sentiment Uniphar Neutral UDG Healthcare Neutral Do institutionals & insiders have more ownership in UPR or UDG? 45.3% of Uniphar shares are held by institutional investors. 10.1% of Uniphar shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts rate UPR or UDG? Uniphar currently has a consensus price target of GBX 310, suggesting a potential upside of 78.16%. Given Uniphar's stronger consensus rating and higher probable upside, equities research analysts clearly believe Uniphar is more favorable than UDG Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Uniphar 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00UDG Healthcare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is UPR or UDG more profitable? Uniphar has a net margin of 1.69% compared to UDG Healthcare's net margin of 0.00%. Uniphar's return on equity of 13.91% beat UDG Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Uniphar1.69% 13.91% 3.76% UDG Healthcare N/A N/A N/A Does the MarketBeat Community prefer UPR or UDG? UDG Healthcare received 513 more outperform votes than Uniphar when rated by MarketBeat users. However, 100.00% of users gave Uniphar an outperform vote while only 74.68% of users gave UDG Healthcare an outperform vote. CompanyUnderperformOutperformUnipharOutperform Votes6100.00% Underperform VotesNo VotesUDG HealthcareOutperform Votes51974.68% Underperform Votes17625.32% Is UPR or UDG a better dividend stock? Uniphar pays an annual dividend of GBX 2 per share and has a dividend yield of 1.1%. UDG Healthcare pays an annual dividend of GBX 0.17 per share and has a dividend yield of 0.0%. Uniphar pays out 1,428.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. UDG Healthcare pays out 0.7% of its earnings in the form of a dividend. Which has better valuation & earnings, UPR or UDG? Uniphar has higher revenue and earnings than UDG Healthcare. UDG Healthcare is trading at a lower price-to-earnings ratio than Uniphar, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUniphar£2.68B0.18£45.17M£0.141,242.86UDG Healthcare£1.25B2.18N/A£25.4042.48 SummaryUniphar beats UDG Healthcare on 12 of the 16 factors compared between the two stocks. Ad InvestorPlaceWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who understand the shifts ahead, this could be the foundation for long-term wealth creation. In this exclusive briefing, I'll show you exactly how to prepare for the challenges and opportunities ahead. You'll learn actionable strategies to protect your portfolio and position yourself for growth in the months and years to come.Click here now to watch the full briefing and discover the steps to take today. Get Uniphar News Delivered to You Automatically Sign up to receive the latest news and ratings for UPR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPR vs. The Competition Export to ExcelMetricUnipharMedical Distribution IndustryMedical SectorLON ExchangeMarket Cap£475.06M£1.08B£5.09B£1.42BDividend Yield0.76%1.30%5.04%11.56%P/E Ratio1,242.8693.53101.481,569.60Price / Sales0.1879.141,207.98219,445.82Price / Cash9.9710.8739.7133.65Price / Book1.361.996.932.81Net Income£45.17M£45.17M£118.81M£157.07M7 Day Performance-1.14%2.70%-1.39%-0.63%1 Month Performance-17.14%3.74%-3.29%3.20%1 Year Performance-4.04%-5.75%32.29%97.44% Uniphar Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPRUnipharN/AGBX 174+3.6%GBX 310+78.2%-4.0%£475.06M£2.68B1,242.863,000UDGUDG HealthcareN/AGBX 1,079flatN/AN/A£2.72B£1.25B42.489,000CLINClinigen GroupN/AN/AN/AN/A£1.23B£565.60M64.691,000EMISEMIS GroupN/AGBX 1,920flatN/A+0.0%£1.23B£176.86M4,085.111,560ONTOxford Nanopore Technologies2.6687 of 5 starsGBX 122.80+0.3%GBX 235.50+91.8%-36.0%£1.16B£167.75M-614.001,281News CoverageGNSGenus2.1449 of 5 starsGBX 1,644-2.5%GBX 2,150+30.8%-22.2%£1.08B£668.80M13,700.00480INDVIndivior2.3733 of 5 starsGBX 837+1.3%GBX 1,500+79.2%-37.8%£1.08B£1.15B-1,046.251,000VECVectura GroupN/AGBX 164.80flatN/A+0.0%£1.01B£190.60M8.209,200SPISpire Healthcare Group2.7223 of 5 starsGBX 216.50+0.2%GBX 322+48.7%-3.8%£874.27M£1.44B3,078.57420News CoverageCTHCareTechN/AGBX 750+0.3%N/A+0.0%£850.02M£495.40M10,714.2911,000CRWCraneware1.8276 of 5 starsGBX 2,220+0.5%GBX 2,700+21.6%+37.9%£784.55M£189.27M8,525.00734High Trading Volume Related Companies and Tools Related Companies UDG Alternatives CLIN Alternatives EMIS Alternatives ONT Alternatives GNS Alternatives INDV Alternatives VEC Alternatives SPI Alternatives CTH Alternatives CRW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:UPR) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Uniphar plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Uniphar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UPR Stock Alerts